AbbVie Uses Intel AI Tech to Improve Research Translations
What’s New: Global biopharmaceutical company AbbVie is leveraging artificial intelligence (AI) and natural language processing (NLP) for research translation, improving collaboration and search capabilities to enable the discovery of new treatments for patients. “We built Abbelfish Machine Translation and AbbVie Search to accelerate and scale the work of our researchers, reducing the time it takes to … Continued
The post AbbVie Uses Intel AI Tech to Improve Research Translations appeared first on Intel Newsroom.